You are currently browsing the Recovery Radio Network Home weblog archives for the day 27. July 2011.
| S | M | T | W | T | F | S |
|---|---|---|---|---|---|---|
| « Jun | Aug » | |||||
| 1 | 2 | |||||
| 3 | 4 | 5 | 6 | 7 | 8 | 9 |
| 10 | 11 | 12 | 13 | 14 | 15 | 16 |
| 17 | 18 | 19 | 20 | 21 | 22 | 23 |
| 24 | 25 | 26 | 27 | 28 | 29 | 30 |
| 31 | ||||||
- Recovery Network (99)
- Uncategorized (2)
- Videos (1)
- 15. May 2012: Is it Murder ?
- 9. May 2012: Addiction Vaccines under Development
- 23. April 2012: My Daddy Drinks Too Much
- 16. April 2012: LSD 'helps alcoholics to give up drinking'
- 4. April 2012: The Dark Side of Addiction
- 28. March 2012: Drug Education Needed for Doctors
- 13. March 2012: Mindfulness Matters !
- 7. March 2012: Single Screening Question can reveal Unhealthy Alcohol usage
- 28. February 2012: Parkinson's Drug Shows Promise when used for Alcohol Dependence
- 23. February 2012: Alcoholism ain't what it used to be !
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- March 2009
Archive for 27. July 2011
Alcoholism Drug Shows Promise
27. July 2011 by stationmanager.
An experimental drug to treat alcohol dependence has shown promising results in three clinical trials in Denmark. The company is now submitting the drug for approval in Europe, The Wall Street Journal reports.
The drug, nalmefene, was tested for its effectiveness in reducing a person’s craving for alcohol. Unlike current drug treatments for alcoholism, nalmefene can be taken with alcohol. Nalmefene blocks a craving mechanism that is regulated by the brain’s opioid receptors, according to the article. Other currently available drugs that treat alcoholism discourage drinking by causing unpleasant side effects when a person drinks even a little bit of alcohol.
The three studies included a total of 2,000 people with alcohol dependence. Half were given nalmefene and half were given a placebo, on an ‘as-needed’ basis, according to a news release by the company, Lundbeck A/S. The study found the drug reduced heavy drinking days and total alcohol consumption within the first month of treatment. The improvement was maintained throughout the yearlong study, according to the company. The most common side effects were dizziness, insomnia and nausea.
The company is not currently planning to request approval for the drug in the United States because it is an older drug and does not have strong patent U.S. patent protection, the article states.
Posted in Recovery Network | 1 Comment »